Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| natural killer cell | 7 studies | 16% ± 1% | |
| plasmacytoid dendritic cell | 6 studies | 20% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of KRI1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2375.67 | 1445 / 1445 | 100% | 28.10 | 183 / 183 |
| pancreas | 100% | 1617.91 | 328 / 328 | 100% | 26.33 | 178 / 178 |
| skin | 100% | 2957.79 | 1809 / 1809 | 100% | 43.36 | 472 / 472 |
| uterus | 100% | 2729.19 | 170 / 170 | 100% | 46.39 | 459 / 459 |
| thymus | 100% | 2803.51 | 653 / 653 | 100% | 37.52 | 604 / 605 |
| ovary | 100% | 2541.81 | 180 / 180 | 100% | 30.18 | 429 / 430 |
| prostate | 100% | 3206.74 | 245 / 245 | 100% | 29.73 | 500 / 502 |
| brain | 99% | 1420.84 | 2626 / 2642 | 100% | 33.62 | 705 / 705 |
| lung | 100% | 2156.60 | 577 / 578 | 99% | 31.23 | 1149 / 1155 |
| breast | 100% | 2195.60 | 459 / 459 | 99% | 30.73 | 1110 / 1118 |
| intestine | 100% | 2449.06 | 966 / 966 | 99% | 24.45 | 523 / 527 |
| bladder | 100% | 2631.86 | 21 / 21 | 99% | 33.64 | 500 / 504 |
| adrenal gland | 100% | 2025.00 | 258 / 258 | 99% | 22.19 | 227 / 230 |
| stomach | 100% | 1721.20 | 359 / 359 | 99% | 22.90 | 282 / 286 |
| kidney | 100% | 1891.44 | 89 / 89 | 98% | 19.96 | 887 / 901 |
| liver | 100% | 1326.81 | 226 / 226 | 97% | 16.32 | 394 / 406 |
| adipose | 100% | 2074.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 32.91 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 50.13 | 29 / 29 |
| spleen | 100% | 4225.40 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 48.58 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 26.92 | 1 / 1 |
| blood vessel | 100% | 1926.30 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1852.67 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 1253.21 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 1736.60 | 895 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000447 | Biological process | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO_0030686 | Cellular component | 90S preribosome |
| GO_0005730 | Cellular component | nucleolus |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | KRI1 |
| Protein name | KRI1 protein Protein KRI1 homolog KRI1 homolog |
| Synonyms | |
| Description | |
| Accessions | B7ZLF4 H0YG91 H0YH26 ENST00000312962.12 ENST00000544397.2 A0A494C108 H0YFD2 F8WFC1 ENST00000539027.5 ENST00000652042.1 ENST00000432197.5 ENST00000543682.3 Q8N9T8 |